期刊文献+

多聚二磷酸腺苷核糖合成酶抑制剂对血管紧张素Ⅱ诱导心脏成纤维细胞基质金属蛋白酶表达的影响 被引量:1

Inhibition of poly(ADP-ribose) polymerase prevented angiotensin Ⅱ induced expression of matrix metalloprotease in cardiac fibroblast
原文传递
导出
摘要 目的:观察多聚二磷酸腺苷核糖合成酶(PARP)抑制剂对血管紧张素Ⅱ(AngⅡ)刺激的乳鼠心脏成纤维细胞基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)和金属蛋白酶组织抑制剂-1(TIMP-1)基因转录的影响。方法:新生SD大鼠心脏成纤维细胞原代培养,传代。用PARP抑制剂——3-氨基苯甲酰胺(3-AB)预处理细胞,观察3-AB对AngⅡ诱导心脏成纤维细胞MMP-2、MMP-9及TIMP-1基因表达的影响。结果:AngⅡ刺激心脏成纤维细胞MMP-2、MMP-9及TIMP-1基因表达明显增加,成纤维细胞内PARP活性及PARP1的表达显著增强。使用3-AB抑制PARP1的活性及表达,可以明显降低AngⅡ诱导的心脏成纤维细胞MMP-2、MMP-9及TIMP-1基因表达的增加。结论:PARP在AngⅡ诱导的心脏重构过程中发挥了重要的调控作用。 Objective:To study the effect of poly(ADP-ribose) polymerase(PARP) inhibitor on cardiac fibroblast treated by angiotensin Ⅱ (Ang Ⅱ ). Method: Cultured 3rd passage cardiac fibroblasts were incubated with PARP inhibitor 3-aminobenzamide (3-AB) for 30 minutes first and then 0.1μmol/L Ang Ⅱ were added to the culture medium. The incubation time was 24 hours. We explored the reactive oxygen species(ROS), the PARP activity and the expression of MMP-2, MMP-9 and TIMP-1 in cardiac fibroblast. Result: Ang Ⅱ induced ROS generation,induced PARP activation and PARP1 expression, 3-AB effectively prevented the expression of matrix MMP- 2, MMP-9 and TIMP-1 in cultured fibroblast treated with Ang Ⅱ. Conclusion:Inhibition of PARP activation prevented Ang Ⅱ induced transcriptional expression of MMP-2, MMP-9 and TIMP-1 in cultured fibroblast.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2008年第3期213-216,共4页 Journal of Clinical Cardiology
基金 国家自然科学基金资助项目(No:30400175)
关键词 血管紧张素Ⅱ 多聚ADP核糖合成酶 心脏 成纤维细胞 基质金属蛋白酶 Angiotensin Ⅱ Poly (ADP-ribose) polymerase Cardiac fibroblast Matrix metalloproteinases
  • 相关文献

参考文献13

  • 1PACHER P, MABLEY J G, SORIANO F G, et al. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging[J]. Int J Mol Med, 2002,9:659-664.
  • 2KOH O, AKIRA M. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remoldeling[J]. Circulation, 1998, 98: 149-156.
  • 3CSABA S, PAL P, ZSUZUANNA Z, et al. Angiotensin Ⅱ-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation[J]. Mol Med, 2004,10:28-35.
  • 4SWYNGHEDAUW B. Molecular mechanisms of myocardial remodeling[J]. Physiol Rev, 1999,79 : 215 - 262.
  • 5WEBER K. Cardiac interstitium[M]// In: POOLEWILSON P, COLUCCI W, MASSIE B, et al, eds. Heart Failure. New York: Churchill Livingstone, 1997:13-31.
  • 6SABBAH H N, SHAROV V G, LESCH M, et al. Progression of heart failure: a role for interstitial fibrosis[J]. Mol Cell Bioehem, 1995,147: 29-34.
  • 7SCHNEE J M, HSUEH W A. Angiotensin Ⅱ, adhesion, and cardiac fibrosis[J]. Cardiovasc Res, 2000, 46:264-268.
  • 8MAISCH B. Extracellular matrix and cardiac interstitium: restriction is not a restricted phenomenon[J]. Herz, 1995,20 : 75 - 80.
  • 9SZABO C, BISER A, BENKO R, et al. Poly(ADP- ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice[J]. Diabetes, 2006, 55: 3004-3012.
  • 10SADOSHIMA J, IZUMO S. Molecular characterization of angiotensinⅡ-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype[J]. Cire Res, 1993,73:413-423.

同被引文献23

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部